Advertisement
Canada markets open in 2 hours 58 minutes

  • S&P/TSX

    21,728.55
    +14.01 (+0.06%)
     

  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • CAD/USD

    0.7288
    +0.0006 (+0.09%)
     

  • CRUDE OIL

    79.58
    +0.58 (+0.73%)
     

  • Bitcoin CAD

    79,121.84
    +365.57 (+0.46%)
     

  • CMC Crypto 200

    1,249.17
    -21.57 (-1.70%)
     

  • GOLD FUTURES

    2,307.00
    -4.00 (-0.17%)
     

  • RUSSELL 2000

    1,980.23
    +6.32 (+0.32%)
     

  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     

  • NASDAQ futures

    17,583.75
    +145.50 (+0.83%)
     

  • VOLATILITY

    15.01
    -0.38 (-2.47%)
     

  • FTSE

    8,150.12
    +28.88 (+0.36%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • CAD/EUR

    0.6807
    +0.0014 (+0.21%)
     

Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024

Business Wire
·1 min read

IRVINE, Calif., April 18, 2024--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results.

To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the "Investor Relations" section of the Edwards website at ir.edwards.com.

About Edwards Lifesciences

Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, X and YouTube.

ADVERTISEMENT

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240418905608/en/

Contacts

Media Contact: Amy Hytowitz, 949-250-4009
Investor Contact: Mark Wilterding, 949-250-6826